Latest Novo Holdings A/S Stock Portfolio
Novo Holdings A/S Performance:
2024 Q4: -2.26%YTD: -3.31%2023: 31.69%
Performance for 2024 Q4 is -2.26%, and YTD is -3.31%, and 2023 is 31.69%.
About Novo Holdings A/S and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Novo Holdings A/S reported an equity portfolio of $1.7 Billions as of 31 Dec, 2024.
The top stock holdings of Novo Holdings A/S are VB, , . The fund has invested 18.2% of it's portfolio in VANGUARD INDEX FDS and 9.7% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off CORCEPT THERAPEUTICS INC (CORT), CABLE ONE INC (CABO) and ALNYLAM PHARMACEUTICALS INC (ALNY) stocks. They significantly reduced their stock positions in SALESFORCE INC (CRM), BROOKFIELD CORP and EDGEWISE THERAPEUTICS INC (EWTX). Novo Holdings A/S opened new stock positions in RECURSION PHARMACEUTICALS IN (RXRX), CERIBELL INC. and MERSANA THERAPEUTICS INC. (MRSN). The fund showed a lot of confidence in some stocks as they added substantially to ZENAS BIOPHARMA INC, MERUS N V (MRUS) and CELLDEX THERAPEUTICS INC NEW (CLDX).
The top stock holdings of Novo Holdings A/S are VB, , . The fund has invested 18.2% of it's portfolio in VANGUARD INDEX FDS and 9.7% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off CORCEPT THERAPEUTICS INC (CORT), CABLE ONE INC (CABO) and ALNYLAM PHARMACEUTICALS INC (ALNY) stocks. They significantly reduced their stock positions in SALESFORCE INC (CRM), BROOKFIELD CORP and EDGEWISE THERAPEUTICS INC (EWTX). Novo Holdings A/S opened new stock positions in RECURSION PHARMACEUTICALS IN (RXRX), CERIBELL INC. and MERSANA THERAPEUTICS INC. (MRSN). The fund showed a lot of confidence in some stocks as they added substantially to ZENAS BIOPHARMA INC, MERUS N V (MRUS) and CELLDEX THERAPEUTICS INC NEW (CLDX).
Novo Holdings A/S Annual Return Estimates Vs S&P 500
Our best estimate is that Novo Holdings A/S made a return of -2.26% in the last quarter. In trailing 12 months, it's portfolio return was -3.31%.
New Buys
| Ticker | $ Bought |
|---|---|
| recursion pharmaceuticals in | 68,374,900 |
| ceribell inc. | 8,509,580 |
| mersana therapeutics inc. | 6,077,500 |
New stocks bought by Novo Holdings A/S
Additions
| Ticker | % Inc. |
|---|---|
| zenas biopharma inc | 39.13 |
| asml holding n v | 24.37 |
| cargo therapeutics inc | 7.75 |
| merus n v | 7.14 |
| celldex therapeutics inc new | 3.77 |
| arrivent biopharma inc | 1.02 |
Additions to existing portfolio by Novo Holdings A/S
Reductions
| Ticker | % Reduced |
|---|---|
| salesforce inc | -20.26 |
| brookfield corp | -19.83 |
| edgewise therapeutics inc | -9.91 |
| alibaba group hldg ltd | -9.68 |
| viridian therapeutics inc | -5.66 |
| crinetics pharmaceuticals in | -3.98 |
Novo Holdings A/S reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| corcept therapeutics inc | -111,598,000 |
| metagenomi inc | -3,906,000 |
| brookfield asset managmt ltd | -29,660,600 |
| spero therapeutics inc | -628,329 |
| cable one inc | -41,416,200 |
| alnylam pharmaceuticals inc | -32,558,900 |
Novo Holdings A/S got rid off the above stocks
Sector Distribution
Novo Holdings A/S has about 55% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 55 |
| Healthcare | 39 |
| Technology | 6.1 |
Market Cap. Distribution
Novo Holdings A/S has about 10.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 55 |
| SMALL-CAP | 21 |
| MID-CAP | 12.6 |
| MEGA-CAP | 5.9 |
| LARGE-CAP | 5 |
Stocks belong to which Index?
About 40.7% of the stocks held by Novo Holdings A/S either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 59.2 |
| RUSSELL 2000 | 34.8 |
| S&P 500 | 5.9 |
Novo Holdings A/S Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Novo Holdings A/S
Novo Holdings A/S has 34 stocks in it's portfolio. About 71.9% of the portfolio is in top 10 stocks. PCVX proved to be the most loss making stock for the portfolio. CRM was the most profitable stock for Novo Holdings A/S last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABCL | abcellera biologics inc | 0.20 | 1,126,920 | 3,301,860 | unchanged | 0.00 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BABA | alibaba group hldg ltd | 2.32 | 452,327 | 38,352,800 | reduced | -9.68 | ||
| BMRN | biomarin pharmaceutical inc | 1.95 | 490,000 | 32,207,700 | unchanged | 0.00 | ||
| BPMC | blueprint medicines corp | 0.92 | 175,000 | 15,263,500 | unchanged | 0.00 | ||
| CABO | cable one inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 1.53 | 1,000,000 | 25,270,000 | added | 3.77 | ||
| CORT | corcept therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRM | salesforce inc | 5.95 | 293,901 | 98,259,900 | reduced | -20.26 | ||
| CRNX | crinetics pharmaceuticals in | 2.97 | 960,215 | 49,095,800 | reduced | -3.98 | ||
| EWTX | edgewise therapeutics inc | 8.08 | 5,000,000 | 133,500,000 | reduced | -9.91 | ||
| FDMT | 4d molecular therapeutics in | 0.51 | 1,500,000 | 8,355,000 | unchanged | 0.00 | ||
| FOLD | amicus therapeutics inc | 1.43 | 2,500,000 | 23,550,000 | unchanged | 0.00 | ||
| GLTO | galecto inc | 0.03 | 99,913 | 464,595 | unchanged | 0.00 | ||
| INSM | insmed inc | 3.03 | 724,666 | 50,030,900 | unchanged | 0.00 | ||
| IOBT | io biotech inc | 0.19 | 3,354,450 | 3,086,090 | unchanged | 0.00 | ||
| MIRM | mirum pharmaceuticals inc | 3.76 | 1,500,000 | 62,025,000 | unchanged | 0.00 | ||
| MQ | marqeta inc | 0.10 | 441,558 | 1,673,500 | unchanged | 0.00 | ||
| MRSN | mersana therapeutics inc. | 0.37 | 4,250,000 | 6,077,500 | new | |||
| MRUS | merus n v | 1.91 | 750,000 | 31,537,500 | added | 7.14 | ||